Internal Medicine Alert (Vol. 39, No. 5) - March 15, 2017

Read the Disclosure Information Below, then click “Continue” to begin testing.

Release date: March 2017

Valid through: March 2020

Target Audience

This CME activity is intended for the internist/family physician.

Subjects

  • Role of Statins in Venous Thromboembolism Prevention
  • American Heart Association Recognizes Cardiorespiratory Fitness Should Be Incorporated Into Risk Calculators
  • Discharge Antibiotic Prescriptions Often Are Inappropriate with Regard to Choice, Dose, Duration
  • Pharmacology Update: Etelcalcetide Injection (Parsabiv)
  • Clinical Briefs: Comparing Treatments for Peripheral Artery Disease Patients; Is the Intestinal Microbiome the Culprit in Obesity?; The Dubious Benefits of Urinalysis in Asymptomatic Patients
  • ECG Review: Are There Definitive Clues?

Objectives

  • Describe new findings in differential diagnosis and treatment of various diseases;
  • Describe the advantages, disadvantages, and controversies surrounding the latest advances in the diagnosis and treatment of disease;
  • Identify cost-effective treatment regimens;
  • Explain the advantages and disadvantages of new disease screening procedures.

Credit Available

Physicians

  • Maximum of 2.0 AMA PRA Category 1 Credits
  • 2.0 AOA Category 2-B credits
  • 1.0 AAFP Credit
  • 2.0 ABIM MOC Credits

Sponsor

This activity is sponsored by AHC Media.

Accreditation Statement

AHC Media is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation

Physicians

AHC Media designates this enduring material for a maximum of 2.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The American Osteopathic Association has approved this continuing education activity for up to 2.0 AOA Category 2-B credits.

This Enduring Material activity, Internal Medicine Alert, has been reviewed and is acceptable for credit by the American Academy of Family Physicians. Term of approval begins Jan. 1, 2017. Term of approval is for one year from this date. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Approved for 1 AAFP Prescribed credit.

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 2 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Faculty Listing

PHYSICIAN EDITOR

Stephen A. Brunton, MD

Adjunct Professor of Pharmacy Practice

College of Pharmacy

Roseman University of Health Sciences

Salt Lake City 

ASSOCIATE EDITORS

James Chan, PharmD, PhD

Pharmacy Quality and Outcomes Manager

Kaiser Permanente

Oakland, CA

 

Stan Deresinski, MD, FACP, FIDSA

Clinical Professor of Medicine
Stanford University

 

William T. Elliott, MD, FACP

Assistant Clinical Professor of Medicine
University of California, San Francisco

 

David C. Fiore, MD

Professor of Family Medicine
University of Nevada, Reno

 

Ken Grauer, MD

Professor Emeritus in Family Medicine

College of Medicine

University of Florida

 

Seema Gupta, MD, MSPH

Clinical Assistant Professor
Department of Family and Community Health
Joan C. Edwards School of Medicine
Marshall University
Huntington, WV

 

Louis Kuritzky, MD

Clinical Assistant Professor

University of Florida

 

PEER REVIEWER

Gerald Roberts, MD

Senior Attending Physician
Long Island Jewish Medical Center NS/LIJ Health Care System

New Hyde Park, NY

Financial Disclosure

Internal Medicine Alert’s Physician Editor Stephen Brunton, MD, is a retained consultant for Abbott Diabetes, Actavis, AstraZeneca, Becton Dickinson, Boehringer Ingelheim, Cempra, Allergan, Janssen, Lilly, Novo Nordisk, and Teva; he serves on the speakers bureau of

AstraZeneca, Boehringer Ingelheim, Janssen, Lilly, Novo Nordisk, and Teva. Contributing Editor Louis Kuritzky, MD, is a retained consultant for and on the speakers bureau of Allergan, Daiichi Sankyo, Lilly, and Lundbeck. Peer Reviewer Gerald Roberts, MD, Executive Editor Leslie Coplin, and Editor Jonathan Springston report no financial relationships relevant to this field of study.

 

Drs. Elliott, Chan, Deresinski, Fiore, and Gupta report no financial relationships relevant to this field of study.

 

Dr. Grauer is the sole proprietor of KG-EKG Press, and publisher of an ECG pocket brain book.

 

Copyright 2017, AHC Media. All rights reserved.